Sanofi
Sanofi has 6 source-linked AI deployments documented in AIUseCaseHub, across 2 industries and 3 countries. Key partners include Exscientia, BenevolentAI, BioMap.
Hyperscaler mix
See whether Sanofi's cases are powered by Microsoft, AWS, GCP, or multiple providers.
How Sanofi builds AI
Build / Buy / Compose across this company's documented cases
5 of 6 cases classified (83%) · Compare all use-case types
Reported outcomes
2 cases report measurable results
−79%
Time & speed
median · 6 metrics
Medians of results published in Sanofi cases, normalized for comparability. See all benchmarks →
Evidence persistence
3 of 3 judgeable cases are still publicly referenced · 3 show the organization expanding AI use.
Durability of public evidence, not whether systems remain in production. How this is measured →
Technology snapshot
What Sanofi uses across visible cases
Capability flags and technologies mentioned in the indexed use cases on this page.
- Top use case
- Fine-tuning
- Tagged cases
- 3/6
- Tech names
- 17
All Use Cases (6)
Sanofi builds Concierge, an agentic generative AI assistant on Amazon Bedrock
Sanofi built Concierge in-house on AWS as a unified, agentic AI companion for its global workforce, using Amazon Bedrock for model flexibility and planning to add Amazon Bedrock AgentCore for orchestration.The system gives employees a single conversational interface for finding information, generating content, completing tasks, and discovering specialized agents across the company.
Sanofi Digital Accelerator uses AWS SageMaker for predictive AI and deploys Bedrock for generative AI pilots
Sanofi launched its Digital Accelerator to speed up digital innovation across research and development, clinical, commercial, and manufacturing workflows.The initiative aims to shorten the time from discovery to therapy and improve patient, provider, and employee experiences through AI-powered solutions.
AWS Healthcare & Life Sciences Generative AI Use Cases and Customer Implementations
AWS supports healthcare and life sciences organizations in deploying generative AI to accelerate drug discovery, improve clinical trial development, enhance medical imaging and pathology analysis, automate clinical documentation, and streamline regulatory compliance.Customers such as Pfizer, Natera, Clario, Aetion, Sanofi, Philips, Hippocratic AI, Solventum, Amazon Pharmacy, and Radboud University Medical Center use AWS technologies to enhance research, care delivery, and compliance workflows.AWS technologies employed include Amazon Bedrock, Amazon SageMaker, AWS HealthScribe, Amazon Textract, and Amazon Comprehend.Applications include rapid drug candidate screening, protocol generation, synthetic defect image generation, compliant content creation, real-world evidence analysis, sales team compliance improvement, clinician task automation, call center productivity, prior authorization automation, and compliance reporting.
Microsoft
AstraZeneca and Novartis Scale AI Across Pharma Value Chain
This article provides a comprehensive overview of how leading pharmaceutical firms—including AstraZeneca, Novartis, Sanofi, GSK, Genentech, and AbbVie—are integrating Microsoft technologies such as Azure AI, Machine Learning, Cognitive Services, and Power Platform to transform drug development and operations. Real-world examples cover AI-powered drug target identification, generative molecule design, clinical trial acceleration, pharmacovigilance, supply chain optimization, and patient engagement via chatbots. The piece details both the tangible business benefits (shortened timelines, reduced costs, improved trial precision, and better patient outcomes) and persistent challenges such as data fragmentation, legacy systems, regulatory complexities, and change management. Strategic priorities for CIOs and IT leaders on how to industrialize AI, ensure enterprise-wide adoption, and promote responsible, cross-functional scaling of Microsoft technologies are emphasized. The article highlights collaborations like AstraZeneca’s enterprise AI roadmap, Novartis-Microsoft innovation lab, and Sanofi’s infrastructure modernization to demonstrate mature, scalable uses of cloud-based AI.Challenges with data interoperability, legacy infrastructure, talent and cultural adoption, and regulatory risk are addressed alongside solutions such as human-in-the-loop designs, explainable AI, and real-time learning cycles aligned with scientific and compliance goals.
Sanofi personalizes cancer treatment and accelerates drug discovery using advanced AI
Sanofi, a global pharmaceutical leader based in France, is leveraging advanced AI and Microsoft Azure technologies to transform two core areas: cancer treatment optimization and dr...
Pharma Investment in AI for Drug Discovery
Pharma companies are increasingly investing in AI to enhance computer-aided drug design (CADD) and reduce drug development time and costs, creating a multibillion-dollar market. Fi...